Piperacillin and Tazobactam for Injection, USP 4.5 grams per vial, Rx only, Mfd for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-004-51
Published May 24, 2023 · Recall initiated: May 15, 2023
Summary
FDA records drug Class II recall D-0625-2023, published May 24, 2023 and initiated May 15, 2023. Recalling firm: Astral SteriTech Private Ltd.; Status: Terminated; Reported quantity: 249,080 vials; Lot: All lots within expiry. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Astral SteriTech Private Ltd.
- Distributor
- Nationwide within the United States
- Lot
- All lots within expiry.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDACeftriaxone for Injection, USP 10 grams per Pharmacy Bulk Package, Rx only, Manufactured for: XelliaMay 24, 2023
- FDAPiperacillin and Tazobactam for Injection, USP, 3.375 grams per vial, Rx only, Mfg. for: Piramal CriticalMay 24, 2023
- FDAAmpicillin and Sulbactam for Injection, USP 3 grams per vial, Rx only, Mfd for Meitheal PharmaceuticalsMay 24, 2023
- FDAAmpicillin and Sulbactam for Injection, USP 1.5 grams per vial, Rx only, Mfd for Meitheal PharmaceuticalsMay 24, 2023
- FDAPiperacillin and Tazobactam for Injection, USP 3.375 grams per vial, Rx only, Mfd for Meitheal PharmaceuticalsMay 24, 2023
- FDAPiperacillin and Tazobactam for Injection, USP, 2.25 grams per vial, Rx only, Mfg. for: Piramal Critical Care,May 24, 2023
Questions about this recall
Was Piperacillin and Tazobactam for Injection, USP 4.5 grams per vial, Rx only, Mfd for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-004-51 recalled?
Yes. FDA published recall D-0625-2023 on May 24, 2023. Reported hazard: Lack of Assurance of Sterility
What should I do if I have this product?
Voluntary: Firm initiated · Letter